文献速递脑血管病

美国心脏协会科学声明:视网膜中央动脉阻塞的管理

Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association.
PubMed 文献 · Stroke · 2021-03-08

该科学声明由美国心脏协会组织多学科专家撰写,通过文献综述与共识形成方式,系统评述了视网膜中央动脉阻塞(CRAO)的急性期治疗与二级预防。声明指出急性CRAO是医疗急症,需优先早期识别与分诊,静脉组织型纤溶酶原激活剂可能有效,并强调应紧急筛查和治疗血管危险因素,同时呼吁开展高质量随机临床试验。

要点

  • 急性CRAO是医疗急症,应优先早期识别与急诊分诊。
  • 静脉组织型纤溶酶原激活剂治疗可能有效。
  • 患者应紧急筛查并治疗血管危险因素以进行二级预防。

核心结论

  • 急性CRAO是医疗急症,诊疗系统应优先早期识别与分诊。
  • 当前文献提示静脉组织型纤溶酶原激活剂可能有效。
  • 患者应接受血管危险因素的紧急筛查与治疗。

研究设计与样本

  • 美国心脏协会组织血管神经病学、神经眼科、玻璃体视网膜手术、免疫学、血管内神经外科和心脏病学专家组成写作组。
  • 对随机对照临床试验、前瞻性与回顾性队列研究、病例对照研究、病例报告、临床指南、综述、基础科学文章和社论进行文献综述。
  • 写作组成员分工检索文献、综合数据并提出实践考量,多轮草案传阅直至达成共识。

主要发现

  • 急性CRAO导致严重视力丧失,并且是进一步脑血管和心血管事件的先兆。
  • 关于CRAO适当管理的科学信息匮乏,多数策略基于观察性文献和专家意见。
  • 不同从业者、机构和亚专科组之间的管理模式存在相当大的差异。

临床怎么用

  • 应将急性CRAO作为医疗急症,优先早期识别并分诊至急诊医疗。
  • 可考虑静脉组织型纤溶酶原激活剂治疗。
  • 应对患者紧急筛查并治疗血管危险因素。

局限性

  • 关于CRAO适当管理的科学信息匮乏,多数策略基于观察性文献和专家意见。
  • 该领域需要高质量随机临床试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Central retinal artery occlusion (CRAO) is a form of acute ischemic stroke that causes severe visual loss and is a harbinger of further cerebrovascular and cardiovascular events. There is a paucity of scientific information on the appropriate management of CRAO, with most strategies based on observational literature and expert opinion. In this scientific statement, we critically appraise the literature on CRAO and provide a framework within which to consider acute treatment and secondary prevention. METHODS: We performed a literature review of randomized controlled clinical trials, prospective and retrospective cohort studies, case-control studies, case reports, clinical guidelines, review articles, basic science articles, and editorials concerning the management of CRAO. We assembled a panel comprising experts in the fields of vascular neurology, neuro-ophthalmology, vitreo-retinal surgery, immunology, endovascular neurosurgery, and cardiology, and document sections were divided among the writing group members. Each member received an assignment to perform a literature review, synthesize the data, and offer considerations for practice. Multiple drafts were circulated among the group until consensus was achieved. RESULTS: Acute CRAO is a medical emergency. Systems of care should evolve to prioritize early recognition and triage of CRAO to emergency medical attention. There is considerable variability in management patterns among practitioners, institutions, and subspecialty groups. The current literature suggests that treatment with intravenous tissue plasminogen activator may be effective. Patients should undergo urgent screening and treatment of vascular risk factors. There is a need for high-quality, randomized clinical trials in this field.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Mac Grory B, Schrag M, Biousse V, et al. Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association. Stroke. 2021. PMID: 33677974. doi:10.1161/STR.0000000000000366

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。